Could a week of radiation be enough for breast cancer?

NCT ID NCT06295744

First seen Jun 24, 2026 · Last updated Jul 24, 2026 · Updated 2 times

Summary

This study is testing a very short course of radiation therapy for women with early-stage breast cancer. Instead of weeks of treatment, participants receive whole breast radiation with a targeted boost over just 5 days. Researchers will track how the breast looks and feels, and how patients rate their quality of life, for up to 5 years. The goal is to see if this ultra-short schedule is both safe and satisfactory for patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Radiation therapy (whole breast irradiation with simultaneous integrated boost)
What this could lead to
If successful, this could show that a shorter, more convenient radiation schedule is just as good for cosmetic outcomes and quality of life as longer courses.
What could go wrong
This is a small, early-phase study with only 50 participants, so results may not apply to everyone. There is also a risk of side effects like skin irritation or fatigue from the radiation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DUCTAL CARCINOMA IN SITU are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UW Carbone Cancer Center

    Madison, Wisconsin, 53792, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.